SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950133-06-000730
Filing Date
2006-02-14
Accepted
2006-02-14 14:41:54
Documents
2
Group Members
VENROCK ASSOCIATES II, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G w17560esc13g.htm SC 13G 58988
2 EXHIBIT 99.1 w17560eexv99w1.htm EX-99.1 3481
  Complete submission text file 0000950133-06-000730.txt   64294
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Subject) CIK: 0000902622 (see all company filings)

IRS No.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81358 | Film No.: 06613117
SIC: 2834 Pharmaceutical Preparations

Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

IRS No.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G